What Atrotech Oy does

Atrotech Oy is a privately held Finnish medical device company headquartered in Tampere that designs, manufactures, and distributes implantable phrenic nerve stimulators used to restore near-natural breathing in patients dependent on mechanical ventilation. Its core product, the Atrostim Phrenic Nerve Stimulator (PNS) V2.5, applies Sequential Multipolar Stimulation through four active Platinum nerve contacts fixed intrathoracically on the phrenic nerve, with radiofrequency inductive powering that eliminates skin-penetrating wires. The platform is positioned for three indications: respiratory muscle paralysis (typically from high-level spinal trauma), central alveolar hypoventilation, and respiratory insufficiency in quadriplegic spinal cord injury patients, with claimed clinical advantages including fatigue-free diaphragm contraction, conditioning periods measured in weeks rather than months, and improved quality-of-life scores versus mechanical ventilation.

The company operates a dual business model. On the product side, Atrotech sells the Atrostim system directly in Finland and through a network of country-specific local representatives in Germany (BÖRGEL GmbH), France (TIDALIUM), Spain and Portugal (Anita Tecnica S.L.), Colombia (RP Médicas S.A.), and Poland (IMC IMPOMED Centrum S.A.), with a Brazil page that currently redirects inquiries back to headquarters. On the services side, Atrotech offers OEM and contract manufacturing for implantable medical devices, including design and production of neurostimulators and electrodes, cleanroom assembly, laser welding, vacuum/nitrogen glove box hermetic packaging with Mil-Std 202/883 leak testing, and EN 13060 steam sterilization validated to ISO 17655-1:2006. Quality management is certified to EN ISO 13485, and the company cites approximately 2,000 cumulative implanted cases over 40+ years with no device-related deaths. The organization is small (6 employees), privately funded with no disclosed external capital, and focused on a stable, ultra-orphan indication rather than scale expansion.

Name

Atrotech Oy

Legal name

Atrotech Oy

Website

https://atrotech.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Atrotech Oy is a Finnish medical device company that designs and manufactures the Atrostim implantable phrenic nerve stimulator (PNS), providing near-natural diaphragm pacing for patients dependent on mechanical ventilators due to respiratory paralysis, central sleep apnea, or spinal cord injuries.

Ownership category

akta.pro rank

Product category

Implantable Neurostimulation Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

Keywords

• Phrenic nerve stimulation
• Diaphragm pacing systems
• Implantable neurostimulators
• Respiratory care devices
• Medical device manufacturing

Headquarters

HQ city

Tampere

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Distribution channels7 records

Marketing channels2 records

Core offering

Atrotech Oy designs, manufactures, and distributes the Atrostim Phrenic Nerve Stimulator (PNS) system, an implantable diaphragm pacing device that uses Sequential Multipolar Stimulation with four active nerve contacts to electrically activate the phrenic nerves and restore near-natural breathing in patients dependent on mechanical ventilators. The company also provides contract manufacturing services for implantable neurostimulators and electrodes, supported by cleanroom, laser welding, glove box hermetic packaging, and sterilization capabilities.

Product overview

Atrotech Oy offers a focused portfolio of medical devices centered on the Atrostim Phrenic Nerve Stimulation (PNS) system. The core offering consists of the Atrostim PNS V2.5 portable neurostimulator with its companion implantable electrodes, which provide electrical activation of the phrenic nerves to restore near-natural breathing in patients dependent on mechanical ventilation. The company operates as both a product manufacturer and an OEM/contract manufacturer, offering design, development, and manufacturing services including cleanroom facilities, laser welding, glove box processes, and sterilization services for implantable medical devices.

Differentiator

Problem solved

Functional benefit

Brands

• Atrostim PNS: Atrostim Phrenic Nerve Stimulator (PNS) - diaphragm pacing system for long-term artificial ventilation using sequential multipolar stimulation

Products and services

• Atrostim PNS V2.5

Quantifiable outcome

• Higher investment paid off after one year of use due to reduced infection frequency and reduced need of single use equipment
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• BÖRGEL GmbHcoreChannel Partner/ Reseller/ DistributorLocal representative for Atrotech products in Germany. Located at An der Meil 4, 65555 Limburg a.d. Lahn, Germany. Contact: +49 6431 94710.
• TIDALIUMcoreChannel Partner/ Reseller/ DistributorLocal representative for Atrotech products in France. Located at 2, impasse des Cabanes, 34600 Les Aires, France. Contact: +33 448 201 555.
• Anita Tecnica S.L.coreChannel Partner/ Reseller/ DistributorLocal representative for Atrotech products in Spain and Portugal. Located at Mirador de la Sierra Nb. 5 & 7, 28035 Madrid, Spain. Contact: +34 913735248.
• RP Médicas S.AcoreChannel Partner/ Reseller/ DistributorLocal representative for Atrotech products in Colombia. Located at Transversal 6 No. 45-135 Patio Bonito, Medellín, Colombia. Contact: +57 4 2684904.
• IMC IMPOMED Centrum S.A.coreChannel Partner/ Reseller/ DistributorLocal representative for Atrotech products in Poland. Located at Skrzyneckiego 38 Str., 03-984 Warsaw, Poland.

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Boston Scientific: Boston Scientific operates a sizable neuromodulation business (Precision spinal cord stimulators, Vercise DBS) and is a relevant broad incumbent peer for implantable neurostimulator manufacturing, regulatory, and commercial models.
• Medtronic: Medtronic is a large incumbent in implantable neuromodulation (spinal cord, deep brain, sacral nerve stimulation). Its broad neurostimulation portfolio and clinical/sales scale make it a comparable reference point for the implantable PNS category, even though it does not currently market a phrenic nerve stimulator.
• Abbott (Neuromodulation): Abbott's neuromodulation division (Proclaim spinal cord stimulators, Infinity DBS) competes in the broader implantable neurostimulator category and serves as a benchmark for scale, reimbursement, and clinical evidence generation in the space.
• LivaNova: LivaNova markets Vagus Nerve Stimulation (VNS) systems for epilepsy and depression and is an established implantable neuromodulation incumbent; it shares regulatory, manufacturing, and clinical-trial dynamics with Atrotech's phrenic nerve stimulator business.

Direct peers

• Avery Biomedical Devices: Avery Biomedical Devices is the most directly comparable peer: it manufactures implantable diaphragm pacing systems (Mark IV Breathing Pacemaker) that electrically stimulate the phrenic nerve in ventilator-dependent patients, the same core use case and patient population as Atrotech's Atrostim PNS.
• Synapse Biomedical: Synapse Biomedical develops the NeuRx DPS diaphragm pacing system, a percutaneous phrenic nerve stimulator for spinal cord injury patients, making it a direct competitor in diaphragm pacing with overlapping clinical indications and customer base.

Emerging players

• Nyxoah: Nyxoah is developing an implantable hypoglossal nerve stimulator (Genio) for obstructive sleep apnea. It is thematically comparable as a small-cap implantable neurostimulator targeting respiratory conditions, with a similar capital-constrained profile to Atrotech.
• Inspire Medical Systems: Inspire is an emerging player in implantable neurostimulation targeting sleep-disordered breathing (hypoglossal nerve stimulation). It overlaps with Atrotech in using electrical nerve stimulation to replace mechanical breathing support, even though the target condition differs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/atrotech-oy

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atrotech Oy